SynopsisThe global market for Aptamers was valued at US$ 341 million in the year 2024 and is projected to reach a revised size of US$ 1138 million by 2031, growing at a CAGR of 19.0% during the forecast period. Aptamers are high affinity molecules that are deriv.....
SynopsisThe global market for Craniomaxillofacial Bone Plate System was valued at US$ 841 million in the year 2024 and is projected to reach a revised size of US$ 1199 million by 2031, growing at a CAGR of 5.2% during the forecast period. The Craniomaxillofacial.....
SynopsisThe global market for Circle Acute Ischemic Stroke was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Acute ischemic stroke occurs when blood flow .....
SynopsisThe global market for Bare Metal Stents was valued at US$ 638 million in the year 2024 and is projected to reach a revised size of US$ 761 million by 2031, growing at a CAGR of 2.6% during the forecast period. This report studies the Bare Metal Stent mar.....
SynopsisThe global market for Mouthguard was valued at US$ 248 million in the year 2024 and is projected to reach a revised size of US$ 393 million by 2031, growing at a CAGR of 6.9% during the forecast period. A mouthguard is a protective device for the mouth t.....
SynopsisThe global market for Syringe-type Digital Dialysate Meter was valued at US$ 72.8 million in the year 2024 and is projected to reach a revised size of US$ 113 million by 2031, growing at a CAGR of 6.5% during the forecast period. The syringe-type digital.....
SynopsisThe global market for Sickle Cell Anemia Therapeutics was valued at US$ 4467 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 15.7% during the forecast period. Sickle cell disease (SCD) .....
SynopsisThe global market for Clinical Trials Storage and Distribution Service was valued at US$ 879 million in the year 2024 and is projected to reach a revised size of US$ 1226 million by 2031, growing at a CAGR of 5.6% during the forecast period. Clinical Tri.....
SynopsisThe global market for PARP (Poly ADP-Ribose Polymerase) Inhibitor was valued at US$ 5551 million in the year 2024 and is projected to reach a revised size of US$ 9999 million by 2031, growing at a CAGR of 8.9% during the forecast period. PARP inhibitors .....
SynopsisThe global market for Eptifibatide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. North American market for Eptifibatide is estimated to increa.....
